Caledonia Vanden Bossche, | |
1255 Kendall Rd, San Luis Obispo, CA 93401-8750 | |
(805) 781-3535 | |
Not Available |
Full Name | Caledonia Vanden Bossche |
---|---|
Gender | Female |
Speciality | Counselor - Mental Health |
Location | 1255 Kendall Rd, San Luis Obispo, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013307677 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Caledonia Vanden Bossche, 1255 Kendall Rd, San Luis Obispo, CA 93401-8750 Ph: () - | Caledonia Vanden Bossche, 1255 Kendall Rd, San Luis Obispo, CA 93401-8750 Ph: (805) 781-3535 |
News Archive
Practices for protecting human research subjects with Alzheimer's disease and other conditions that make them incapable of giving informed consent are widely variable and in need of more concrete ethical and legal guidance, according to a study in IRB: Ethics & Human Research.
Medulloblastomas constitute the most frequent class of malignant childhood brain tumor. Tumors of this type arise due to the uncontrolled proliferation of immature nerve cells in the developing brain, and there is no targeted treatment available.
Although the majority of Canadians believe in a mind/body connection, agreeing how they feel physically is related to how they feel emotionally (87 per cent), only half make the link when it comes to depression.
A revolutionary daily oral vitamin spray by health pioneers BetterYou can boost vitamin D levels in deficient children, particularly common in those with epilepsy.
Bionomics Limited, a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of diseases of the central nervous system (CNS) and cancer, today reported positive data from the completed Phase 1 multiple ascending dose, placebo controlled clinical trial of BNC210, an orally administered negative allosteric modulator of the alpha-7 nicotinic acetylcholine receptor (alpha-7 receptor) being developed for the treatment of anxiety and depression.
› Verified 1 days ago
Mr. Jeff Michael Lloyd, LPT Counselor Medicare: Not Enrolled in Medicare Practice Location: 2945 Mcmillan Ave, Suite 136, San Luis Obispo, CA 93401 Phone: 805-781-4286 | |
Ms. Jordan Alexandra Hall, Counselor Medicare: Not Enrolled in Medicare Practice Location: 277 South St, Suite Y, San Luis Obispo, CA 93401 Phone: 805-541-5144 | |
Jose De Jesus Eulloqui, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1255 Kendall Rd, San Luis Obispo, CA 93401 Phone: 805-781-3535 | |
Mr. Jeffrey White, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2180 Johnson Ave, San Luis Obispo, CA 93401 Phone: 805-781-1295 | |
Kimberly Seaman, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2178 Johnson Ave, San Luis Obispo, CA 93401 Phone: 805-781-4700 | |
Matthew Dean, Counselor Medicare: Not Enrolled in Medicare Practice Location: 4251 S Higuera St Ste 300, San Luis Obispo, CA 93401 Phone: 510-214-2767 | |
Jene Nicole Hinton-railsback, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2180 Johnson Ave, San Luis Obispo, CA 93401 Phone: 805-305-4028 |